This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Immunitas Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Alexandria Fusco: Innovator in Antibody Therapeutics
Introduction
Alexandria Fusco is a prominent inventor based in Derry, NH (US), known for her contributions to the field of antibody therapeutics. With a focus on innovative solutions for treating disorders associated with CD161, she has made significant strides in her research and development efforts. Alexandria holds 2 patents, showcasing her commitment to advancing medical science.
Latest Patents
Her latest patents include groundbreaking work on anti-CD161 antibodies and their uses. The invention relates to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods of using these antibodies for treating disorders associated with or mediated by CD161, such as certain cancers. Additionally, the invention encompasses expression vectors and host cells for producing these antibodies, highlighting the potential for therapeutic applications.
Career Highlights
Alexandria is currently associated with Immunitas Therapeutics, Inc., where she continues to push the boundaries of antibody research. Her work is instrumental in developing new treatments that could significantly impact patient care and outcomes.
Collaborations
Some of her notable coworkers include Alison Tisdale and Uli Bialucha, who contribute to the collaborative environment at Immunitas Therapeutics, Inc. Their combined expertise fosters innovation and enhances the research capabilities of the organization.
Conclusion
In summary, Alexandria Fusco is a dedicated inventor whose work in antibody therapeutics is paving the way for new treatment options. Her innovative patents and collaborative efforts reflect her commitment to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile